Ochre Bio Taiwan Ltd
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Ochre Bio’s key technology pillars include a Human Discovery Platform (combining patient liver data with gene perturbation atlases), a Human Validation Platform (using perfused livers, diseased tissue slices, and primary cells), and an RNA Therapeutics Pl
Founded Year
2021
Unified Business No.
90531036
Status
Active
Number of Employees
8
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Ochre Bio is a biotech company focused on chronic liver disease therapeutics, aiming to eliminate the need for liver transplants. Their platform integrates human liver data, AI‑driven genomics, and in‑house validation using perfused human liver tissue to uncover novel disease pathways and drug targets.
Corporate Video
